Novo petitions FDA to require Victoza copies to go through clinical trials, pointing to complex manufacturing | Fierce Pharma
![Novo Nordisk receives FDA approval for Saxenda® (liraglutide [rDNA origin] injection) for chronic weight management](http://photos.prnewswire.com/prnfull/20141224/166096 "Novo Nordisk receives FDA approval for Saxenda® (liraglutide [rDNA origin] injection) for chronic weight management")
Novo Nordisk receives FDA approval for Saxenda® (liraglutide [rDNA origin] injection) for chronic weight management
Novo Nordisk settles patent infringement lawsuit with Novartis — MedWatch
Novo Nordisk Pharmaceutical 00169406012 - McKesson Medical-Surgical
Novo Nordisk's diabetes med Victoza chops cardiovascular risks by 13% | Fierce Pharma
Did Novo Illegally Use Diabetes Educators to Boost Drug Sales? | Insulin Nation
Mixed reaction to Novo Nordisk obesity trial - PMLiVE
NICE shuns Novo Nordisk's obesity med Saxenda, citing CV questions | Fierce Pharma
Pharmaceutical Stocks Eye A Big New Market For Their Diabetes Drugs: Obesity | Investor's Business Daily
Novo Nordisk Pharmaceutical 00169406013 - McKesson Medical-Surgical
![Novo Nordisk announces Saxenda® (liraglutide [rDNA origin] injection) is now commercially available in the United States](https://photos.prnewswire.com/prnfull/20150421/200095 "Novo Nordisk announces Saxenda® (liraglutide [rDNA origin] injection) is now commercially available in the United States")
Novo Nordisk announces Saxenda® (liraglutide [rDNA origin] injection) is now commercially available in the United States
FDA Approves Novo Nordisk's Saxenda as a Treatment for Chronic Weight Management
Victoza Liraglutide Pen Injection, Novo Nordisk, 3ML, Packaging Size: 1 X 1 at Rs 4800/piece in Nagpur
/cloudfront-us-east-2.images.arcpublishing.com/reuters/QKOPLCUOOVIV5EFKGE7WWNSN3U.jpg "U.S. experts recommend weight-loss drugs for obese children | Reuters")
U.S. experts recommend weight-loss drugs for obese children | Reuters
Novo's Victoza has been approved in the EU - Nordic Life Science – the leading Nordic life science news service
Paula Deen's Pharma Deal Suspended by Novo Nordisk - Eater
A package of Victoza (Liraglutide) injectors, manufactured by Novo Nordisk, prescription pharmaceuticals photographed in a pharmacy Stock Photo - Alamy
Novo Nordisk Liraglutide VICTOZA, Non prescription, Treatment: Insulin at Rs 3350/pice in New Delhi
